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ABSTRACT
Background: There are numerous reports from different countries documenting a change 
in frequency and profile of lymphomas after the onset of the HIV/AIDS pandemic. In 
Uganda little is known concerning the distribution of lymphoma subtypes diagnosed 
at the Department of Pathology, Makerere University College of Health Sciences 
during this period.
Objective: To examine the frequency and diagnostic profile of lymphomas diagnosed 
in Uganda in the HIV/AIDS era.
Design: Retrospective study.
Setting: Department of Pathology, Makerere University College of Health Sciences, 
Kampala, Uganda.
Subjects: One thousand and thirteen patients diagnosed with lymphomas in the period 
1980-1989. 
Results: The most common type of non-Hodgkin lymphoma was Burkitt lymphoma 
(36%). The frequencies of lymphocytic and histiocytic types were 34.5% and 8.2% 
respectively.
Conclusion: There was a decrease in histopathologically diagnosed lymphomas in 
Uganda in the period 1980-1989. Burkitt lymphoma continues to be the most common 
subtype diagnosed, some major lymphoma subtypes like T-cell and follicular 
lymphomas were not reported in the country in the HIV/AIDS era.
 
INTRODUCTION
Lymphomas have been found to increase during the 
HIV/AIDS pandemic in most populations. In the 
United States the increase of non-Hodgkin lymphoma 
(NHL) has been estimated to be 100-fold in the 
population of HIV-positive patients. Most of these 
cases are in the high-grade group. A nearly 10-fold 
increased risk of Hodgkin lymphoma (HL) and a 
nearly 60-fold increased risk of NHL have been found 
among HIV-positive individuals in Europe (1, 2). 
  In Africa, there are conflicting reports on 
the relationship between lymphomas and HIV/
AIDS with some reports indicating an increase in 
incidence whereas some studies showed no increase 
in lymphoma cases among HIV/AIDS patients. 
An autopsy series from the Ivory Coast did not 
provide any evidence for an increase of frequency 
of childhood lymphoma (3). However, data from 
population-based cancer registries throughout Africa 
indicate an increase in the incidence of NHL. A study 
by Wabinga et al (4) found a two-fold, statistically 
significant increase in NHL in Kyadondo County in 
Uganda. The HIV/AIDS prevalence in Uganda was 
reported to be about 30% in the 1980-1989 period (5). 
This high prevalence of HIV would be expected to 
have had an impact on the pattern of lymphomas in 
Uganda. 
 The distribution of different lymphoma subtypes 
as investigated using pathology laboratory-based data 
was last published in 1973 (6). Most of the studies 
carried out in Uganda have been from a population-
based cancer registry and often does not include 
lymphoma subtypes (4, 5, 7, 8). Our study is based 
exclusively on the diagnosis as found in the histology 
reports “pathology based data” retrieved from the 
files of the “Department of pathology”. 
 The updated WHO classi f icat ion of 
lymphomas includes integration of morphological, 
immunophenotypical and molecular methods. The 
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standard examination method used in our laboratory, 
however, is light microscopy of haematoxylin and 
eosin (H&E) stained sections. The purpose was to 
examine the profile of lymphomas diagnosed in 
the HIV/AIDS era. We also compared our data to a 
similar study carried out in the 1960s (6). Our findings 
highlight trends in the occurrence of diagnosed 
lymphoma subtypes and reveal the current state of 
lymphoma histopathology in Uganda. 
MATERIALS AND METHODS
Sampling method: Consecutive, purposive sampling 
was used. 
Design: Retrospective study. 
Rationale for the method: The Department of Pathology, 
Makerere University College of Health Sciences has 
been the sole provider of diagnostic histopathology 
for the entire country of Uganda up to 1990. The 
population of Uganda was estimated to be 16.7 
million according to the 1990 Uganda population and 
housing census as compared to 9.5 million in 1969. 
H&E staining remains the only stain used for routine 
diagnosis in the Department of Pathology, as was 
the case in the 1960s. The same method of review of 
histology records is acceptable and used for most of 
the data originating from population-based cancer 
registries. Histopathologic examination and diagnosis 
also form the basis of patient treatment.
Procedure: Records of cases of lymphoma diagnosed 
in the years 1980-1989 and coded as ICD-10 codes 200, 
201, 202 or C81-C85 were retrieved from the files of 
the Department between January and September 2005. 
Data including age, site of biopsy and histological 
diagnosis were obtained from the request forms. The 
NHL were categorised as low or high grade according 
to the criteria from the Kiel classification.
Setting: Department of Pathology, Makerere 
University College of Health Sciences, Kampala, 
Uganda.
Inclusion criteria: All recorded cases of lymphoma 
between 1980-1989.
Exclusion criteria: Leukaemia and cases without 
specified type.
Data handling: The forms with the required data were 
retrieved from the archives; data registered on coded 
forms, and then computerised. Analysis was done 
using the Epi-info software package.
RESULTS 
A total of 1013 patients were recorded with a 
diagnosis of lymphoma in the period 1980-1989. 
Eight hundred and thirty nine cases with the 
histological type specified were included in further 
analysis. Gender was specified in 714 cases. Male 
preponderance was observed in the majority of 
lymphoma subtypes (Table 1). The results were 
compared to the data of D.H.Wright from 1964-1968 
(6). There were 619 (82.5%) non Hodgkin lymphoma 
(NHL) cases in 1964-1968 compared to 740 (88.2%) 
in 1980-1989 and 128 (17.5%) Hodgkin lymphoma 
(HL) cases in 1964-1968 compared to 99 (11.8%) in 
1980-1989. NHL were 7.5 times more common than 
HL in 1980-1989 compared to 4.8 times in the pre-
HIV/AIDS period. 
Table 1 
Gender and distribution of Hodgkin and non-Hodgkin’s 
lymphomas diagnosed at the Department of Pathology, 
Makerere University College of Health Sciences in 
1980-1989
Lymphoma        Number    M:F
type  Males (M)  Females (F)  ratio
Total 460 254 1.8:1
HL 82 26 3.2:1
NHL 378 228 1.7:1
BL 154 105 1.5:1
Histiocytic 39 20 2:1
Lymphocytic 166 86 2:1
Immunoblastic 12 11 1:1
Plasma cell 
lymphomas 7 6 1:1
HL = Hodgkin Lymphoma NHL= Non Hodgkin 
Lymphoma BL = Burkitt Lymphoma 
125 cases lacked information on gender and are 
therefore not included in the table.
Table 2 shows the distribution of the different 
histological types of NHL in the two periods. Low-
grade lymphomas were more frequent in the 1980-
1989 series. In contrast, Burkitt lymphomas were 
diagnosed more often in 1964-1968. There was a 
statistically significant difference in occurrence of the 
histiocytic subtype (p<0.01) in the two time periods 
and the high-grade lymphoblastic and immunoblastic 
subtypes were not reported in the 1964-1968 period. 
There was no statistically significant difference in 
the proportion of Burkitt (p=0.25) or lymphocytic 
(p=0.06) lymphomas in the two periods.
 Looking at the Hodgkin lymphomas (Table 3), 
there was a statistically significant difference in the 
occurrence of subtypes; nodular sclerosis (p=0.02), 
lymphocyte-depleted (p<0.01) and lymphocyte-
228 EAST AFRICAN MEDICAL JOURNAL May 2009 
Table 2
Frequency of the different NHL subtypes as diagnosed at the Department of Pathology, Makerere University in two 
time periods
                       Frequency
NHL 1964-1968 1980-1989 P-value τ2
Histological subtype No.   (%) No.   (%)
†Burkitt 272   44.0 264   35.7 0.25 1.33
†Histiocytic 167   27.0 61   8.2 <0.01 12.4
§Lymphocytic 134   21.6 255   34.5 0.06 0.73
†Lymphoblastic * 121   16.4  
†Immunoblastic * 24   3.2  
†Plasma cell lymphomas 46   7.4 15   2.0 0.08 2.90
*=Not diagnosed in the 1964-1968 period †=High grade lymphomas, § =Low grade lymphoma
Table 3 
Frequency of Hodgkin lymphoma subtypes as diagnosed at the Department of Pathology, Makerere University in 
two time periods
                       Frequency 
HL subtype 1964- 1968 1980- 1989 P-value τ2
 No.   (%) No.   (%) 
Nodular sclerosis 15   11.7 15   15.2 0.02 5.26
Lymphocyte-depleted 25   19.5 13   13.1 <0.01 14.40
Lymphocyte-predominant 23   18.0 24   24.2 <0.01 11.54
Mixed cellularity 65   50.8 47   47.5 0.13 2.18
Total 128   100 99   100  
predominant (p<0.01) in the two time periods. 
The mixed cellularity type was the most common 
subtype of Hodgkin lymphoma in both series. The 
highest number of cases of all lymphomas was in the 
youngest age groups (up to 19 years) and the lowest 
number in the elderly (Figure 1). Burkitt lymphoma 
was most often observed in children younger than 
ten years (Figure 2). There was a steep decline in 
the number of cases after 19 years of age. The non-
Burkitt lymphomas were relatively more common 
in the series from 1980-1989 compared to that from 
1964-1968. Moreover, the non-Burkitt lymphomas 
had a bimodal age distribution in 1980-1989 and a 
unimodal age distribution in 1960-1964 (Figure 3). 
There was an almost uniform age distribution for 
HL during the two time periods (Figure 4).
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Figure 1
Age group distribution for all lymphoma patients included in the study. The distribution of diagnosed lymphomas 
cases has not changed after the onset of the HIV/AIDS pandemic
Figure 2
Age group distribution for all patients with BL diagnosed in the two time periods studied. The distribution of BL 
cases has not changed after the onset of the HIV/AIDS pandemic
Figure 3
Age group distribution for all patients with non-Burkitt NHL in the two time periods examined. In the 1980-1989 
series, the age distribution has been skewed towards the younger age groups, resulting in a bimodal distribution 
pattern
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DISCUSSION
Our data show a decrease in the occurrence of 
histologically diagnosed lymphoma cases in the 
HIV/AIDS (1980-1989) period compared to the pre-
HIV/AIDS (1964-1968) period. The male to female 
ratio of 1.8:1 for lymphomas diagnosed in 1980-1989 is 
almost similar to that found among Ugandan patients 
by other authors (1.67:1) but is different from the 2.5:1 
found in other parts of Africa (9-11). The reduction of 
diagnosed lymphomas occurred despite an increase 
in the Ugandan population from 9.5 million in 1969 to 
16.7 million in 1991. The exact cause of the decrease 
of diagnosed cases is not known but may be due 
to poorer health services as shown by the health 
indicators in 1989 compared to 1969 (12). This may 
have led to a reduced number of biopsied cases or 
the use of other laboratory facilities at hospitals that 
formerly used the University pathology laboratory. 
There may also have been greater reliance on clinical 
diagnosis and other investigative techniques like 
radiology. We also have considered the possibility for 
an actual decrease in the occurrence of lymphomas. 
We think this is rather unlikely. Lymphomas have 
been reported to be on the increase in Africa as well 
as in other countries partly because of HIV association 
with the frequency of NHL reported to be higher than 
that of HL (4, 13-15). Previous studies have reported 
an association between NHL and HIV, although some 
studies have concluded that the incidence of NHL has 
remained relatively stable (1, 7, 8, 16). Our results, 
however, do not reflect the six-fold relative risk of 
developing NHL among HIV patients reported in 
one study in Uganda (17). 
 Burkitt lymphoma remains the most common 
lymphoma subtype diagnosed. This could indicate 
the aetiological factors related to this tumour are stable 
and that diagnostic criteria concerning this subtype 
have not changed. The association between HIV and 
BL remains confusing with some studies suggesting 
that Burkitt lymphoma in children is not associated 
with HIV infection and other studies indicating an 
association (5, 7, 17, 18). In our study, there were fewer 
cases of BL reported in the 1980s compared to the pre-
HIV/AIDS era. Most cases of BL occurred in childhood 
and we observed no change in the age distribution of 
BL during the two time periods (Figure 2). This may 
be explained by BL not being associated with HIV or by 
a poor survival of children with BL and perinatal HIV. 
There could also be fewer cases biopsied or a change 
from use of biopsy to fine-needle aspiration cytology 
and smears for diagnostic purpose. The change in 
classification systems may have led to cases previously 
classified as BL being categorised as new entities like 
the lymphoblastic lymphomas in the last period. These 
subtypes may share morphologic features like starry 
sky pattern (19).
 There was an increase in the proportion of the 
non Burkitt NHL in the 1980-1989 series as compared 
to the pre-AIDS era and this was noted mainly in 
the young age group (Table 2, Figure 3). There was a 
statistically significant difference in the frequency of 
histiocytic lymphomas in the two time periods. This 
is most likely due to adoption of new classification 
systems and terminology. Previous studies have 
reported that high-grade lymphomas, especially the 
diffuse large B-cell lymphomas (DLBCL), comprised 
the majority of lymphoma cases in Uganda (18, 20). 
Lymphoblastic, immunoblastic and plasmablastic 
lymphomas are high grade lymphomas (21). 
The lymphoblastic and immunoblastic subtypes 
contributed to 19.6% of the cases in 1980-1989 and 
Figure 4
Age group distribution for all patients with Hodgkin lymphoma diagnosed in the two time periods examined. The 
distribution has not changed substantially
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are not reported in the 1964-1968 period but this may 
be due to change in classification systems used. The 
group of plasma cell lymphomas most likely includes 
immunoblastic, myelomas and the recent defined 
group of plasmablastic lymphomas. These subtypes 
may be difficult to distinguish morphologically (19, 
22). True histiocytic lymphoma is infrequent and can 
imitate other high grade large cell NHL (19, 23, 24). In 
both periods the diagnosis of histiocytic lymphoma 
has been used comprising a number of different high 
grade lymphoma subtypes like centroblastic, large cell 
anaplastic, true histiocytic and also immunoblastic 
in the pre-AIDS period. 
 Most HIV lymphomas are also reported to be 
high grade with two major histologic categories, 
diffuse large B-cell lymphoma (DLBCL) and BL 
(25). The boundary between BL with and without 
plasmacytoid differentiation is however indistinct and 
this change in morphology may be related to tumour 
site as well (26).The tumour type in AIDS is postulated 
to relate to presence of Epstein-Barr virus infection, 
genetic changes, degree of immune suppression 
and human herpes virus 8 (HHV8) infection (14). 
Recently lymphomas with morphologic features 
of immunoblastic lymphoma have been diagnosed 
immunophenotypically as plasmablastic lymphoma 
and HIV associated (27, 28). There is no convincing 
finding in our study that high grade lymphomas with 
plasmablastic differentiation (plasma cell lymphoma 
and immunoblastic together) have increased in the 
HIV era. 
 The complete absence of reported follicular 
lymphomas in the 1980-1989 series was surprising. 
This lymphoma subtype is more often seen in the 
elderly patients and the lack of diagnosed cases 
may be explained by the young age of our patients. 
Other types of lymphomas not reported in our series 
include mycosis fungoides, central nervous system, 
body cavity-based and T-cell lymphomas. These 
lymphomas are reported to be rare or have not been 
documented in Africa, although some are AIDS-
associated (9, 29). The lack of ancillary diagnostic 
methods most likely contributed to the lack of these 
subtypes.
 While studies in the West reported an increased 
incidence of HL among patients with HIV, the 
situation in Uganda is not clear (5, 7, 30). The 
statistically significant difference in the frequency 
of the subtypes during the two time periods could 
suggest that HIV/AIDS may have had an effect on 
the HL subtypes in Uganda (Table 3). Other authors 
have not found any association between HL and AIDS 
infection in Equatorial Africa (20).The change could 
also be partly attributed to changes in diagnostic 
criteria. The commonest subtype among HIV/AIDS 
patients in Europe is the mixed cellularity type (2, 
31). We found, however, no statistically significant 
difference in the occurrence of the mixed cellularity 
subtype, hence HIV/AIDS may not have any effect 
on this subtype in Uganda.
Limitations: Due to poor quality of the stored slides 
and blocks we were unable to review the histological 
diagnosis. The lymphoma classification systems 
differed between the two periods and ancillary 
techniques like immunohistochemistry were not 
used for subtyping of lymphomas during the time 
periods examined. 
In conclusion, Burkitt lymphoma continues to be the 
most common subtype of lymphoma diagnosed in 
Uganda. There was a statistically significant difference 
in the frequency of some NHL and HL subtypes as 
compared to the 1960s. Some lymphoma subtypes 
have not been reported in Uganda in the HIV/AIDS 
era. We recommend that it is necessary to implement 
up-to-date lymphoma classification systems and 
ancillary techniques like immunohistochemistry in 
Uganda. 
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